IRCT201103166080N1已完成2 期
Effects of additive therapy of losaretan in chronic obstructive pulmonary disease
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 35 years 至 85 years（—）
- 性别
- All
入选标准
- •history of chronic obstructive lung disease base on spirometry data and clinical sign and symptoms referred by pulmonologist. Exclusion criteria: congestive heart failure; myocardial infarction in 6 months ego; consumption of angiotensine converting enzyme inhibitors and angiotensine receptor blockers; dehydration; renal artery stenosis; hyperkalemia; uncontrolled hypertension; allergy to losaretan.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
The evaluation of the effect of losartan on central blood pressure via sympathetic tone and endothelial functioHypertensionJPRN-UMIN000005653The Second Department of Internal Medicine Tokyo Medical University50
已完成
3 期
Investigation Effect of losartan NAFLD patientsAFLD.Fatty (change of) liver, not elsewhere classifiedK76.0IRCT20180412039283N1Shahid Beheshti University of Medical Sciences250
已完成
不适用
Comparison of two treatment regimens in reduction of proteinuria in diabetic patientsDiabetic nephropathy.Glomerular disorders in diabetes mellitusN08.3*IRCT2012121311743N1Tabriz University of Medical Sciences44
已完成
3 期
Effect of losartan on intraocular pressure changesIRCT20210125050134N1Esfahan University of Medical Sciences42
已完成
不适用
Combination therapy of losartan plus hydrochlorothiazide versus any angiotensin II blocker plus any calcium antagonist: effects on blood pressure and cardiac functioEssential hypertensionJPRN-UMIN000012487Department of Cardiology, Osaka Medical College26